Fernando Viesca has a 24-year-old son who suffers from Angelman Syndrome, a little known chromosomal disorder that has left him with significant functional deficiencies. When Nando lived at home, his father took care of him full time, thus alleviating any worries about medical care. However, now that Nando lives in a group home, his father is no longer available to care for him around the clock. This raises many concerns about his son's welfare, especially with Nando's inclination to wander off. Nando's inability to communicate and his new lifestyle raised many questions: What would happen to Nando if he were taken to a hospital without his father's knowledge? How would the medical staff learn Nando's name or that of his father? How would they know how to contact Nando's family? How would they find his primary care physician or learn what medications he is taking? Most importantly, how would they learn that Nando has Angelman syndrome? In this article, the author describes Viesca's search for a technology that could provide a powerful and secure method of conveying his son's vital identification and medical information. The author describes how Viesca learned about an implantable RFID (Radio Frequency Identification) microchip offered by VeriChip Corp., which could be loaded with medical information.